文献速递头颈外科

根治性治疗的口咽鳞状细胞癌患者常规随访的价值

Value of routine follow-up in oropharyngeal squamous cell cancer patients treated with curative intent.
PubMed 文献 · Head Neck · 2022-12-24

该回顾性队列纳入2006至2012年间307例接受根治性治疗的口咽鳞状细胞癌患者,比较无症状与有症状发现新发病变的治疗意图和总生存(OS)。3年和5年新发病变风险分别为29%(95%CI:24-34)和33%(95%CI:27-39);81例局部区域复发或第二原发头颈癌中8例(10%)为无症状发现,其OS与有症状发现者无差异。结论:常规随访中无症状发现新发病变与OS改善无关,随访重点应放在心理社会支持和康复上。

要点

  • 3年和5年新发病变风险分别为29%(95%CI:24-34)和33%(95%CI:27-39)。
  • 81例局部区域复发或第二原发头颈癌中8例(10%)为无症状发现。
  • 无症状发现者OS与有症状发现者无差异。

核心结论

  • 常规随访中无症状发现新发病变与总生存改善无关。
  • 随访重点应放在提供心理社会支持和康复上。

研究设计与样本

  • 回顾性队列研究,纳入2006至2012年间307例连续接受根治性治疗的口咽鳞状细胞癌患者。
  • 通过比较无症状与有症状发现新发病变患者的治疗意图和总生存来评估常规随访的效果。

主要发现

  • 3年和5年新发病变风险分别为29%(95%CI:24-34)和33%(95%CI:27-39)。
  • 81例局部区域复发或第二原发头颈癌患者中,8例(10%)为无症状发现。
  • 无症状发现新发病变者的OS与有症状发现者无差异。

临床怎么用

  • 作者认为随访重点应放在提供心理社会支持和康复上。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The major goal of routine follow-up in oropharyngeal squamous cell carcinoma (OPSCC) patients is the asymptomatic detection of new disease in order to improve survival. This study evaluated the effect of routine follow-up on overall survival (OS). METHODS: A retrospective cohort of 307 consecutive OPSCC patients treated with curative intent between 2006 and 2012 was analyzed. The effectiveness of routine follow-up was studied by comparing treatment-intent and OS in patients with asymptomatically versus symptomatically detected new disease. RESULTS: Three- and five-year risks of new disease were 29% (95% CI: 24-34) and 33% (95% CI: 27-39). Of the 81 patients with locoregional recurrence or second primary head and neck cancer, 8 (10%) were detected asymptomatically with no difference in OS with those detected with symptoms. CONCLUSIONS: Asymptomatic detection of new disease during routine visits was not associated with improved OS. The focus of follow-up should be on providing psychosocial care and rehabilitation.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Brands MT, Swinkels IJ, Aarts AMWM, et al. Value of routine follow-up in oropharyngeal squamous cell cancer patients treated with curative intent. Head Neck. 2022. PMID: 36565244. doi:10.1002/hed.27269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。